feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Counterfeit rabies vaccine alert issued

trending

India U19 World Cup squad

trending

Gambhir's fate depends on T20

trending

Jurrien Timber injury unites Arsenal

trending

Nigeria vs Tunisia AFCON match

trending

Juventus faces Pisa Saturday

trending

Kartik Aaryan film earns crores

trending

Spalletti explains Juventus changes

trending

De'Aaron Fox out versus Jazz

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / TGA Warns on Diabetes Drug Side Effects

TGA Warns on Diabetes Drug Side Effects

1 Dec

•

Summary

  • Mental health warnings issued for GLP-1 agonists.
  • Contraception effectiveness may be reduced by Mounjaro.
  • Suicidal thoughts are a potential side effect to monitor.
TGA Warns on Diabetes Drug Side Effects

The Therapeutic Goods Administration (TGA) has introduced critical safety alerts concerning widely used GLP-1 receptor agonist medications, including Ozempic, Wegovy, Saxenda, Trulicity, and Mounjaro. These drugs, primarily prescribed for diabetes and weight management, are now flagged for potential mental health side effects.

Doctors are advised by the TGA to closely monitor patients for any signs of depression, suicidal ideation, or unusual behavioral changes. This proactive measure addresses reported instances of suicidal behavior and ideation associated with this class of drugs, emphasizing the need for careful patient observation.

Furthermore, the TGA issued a specific warning regarding Mounjaro and its impact on contraception. A potential for reduced effectiveness of oral contraceptives has been identified when initiating or increasing Mounjaro dosage. Patients using oral contraceptives are now advised to use non-oral methods or barrier contraception for a period after starting or adjusting Mounjaro.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The TGA warns of potential suicidal thoughts and mood changes with Ozempic and similar GLP-1 medications.
Yes, the TGA warns Mounjaro may reduce the effectiveness of oral contraceptives, recommending alternative methods.
The TGA has issued warnings for GLP-1 receptor agonists, including Ozempic, Wegovy, Saxenda, Trulicity, and Mounjaro.

Read more news on

Healthside-arrow

You may also like

Ozempic Knock-Offs: Are They Safe?

18 Dec • 55 reads

article image

GLP-1s Reshape Festive Feasts and Fridges

7 Dec • 118 reads

article image

Weight-Loss Drugs Reshape Economy

1 Dec • 158 reads

Mineral Sunscreens Deceive: Cheaper Dupes Offer Same Protection

28 Nov • 116 reads

article image

Nature's Ozempic? Berberine's Weight Loss Claims Explored

28 Nov • 158 reads

article image